Kelly O'Brien Wilson - 25 Jul 2022 Form 3 Insider Report for Immune Therapeutics, Inc.

Reporting relationship
COO and ICEO and IP, 10%+ Owner
Issuer ticker
N/A
Reported as of
25 Jul 2022
Net transaction value
$0
Source evidence Original filing metadata and source links for verification. 3 source fields
SEC form
3
Accepted by SEC
15 Dec 2022, 15:44:39 UTC
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Kelly O'Brien Wilson

Key filing fact

Kelly O'Brien Wilson filed Form 3 for Immune Therapeutics, Inc. on 15 Dec 2022.

Key facts

  • This page summarizes Kelly O'Brien Wilson's Form 3 filing for Immune Therapeutics, Inc..
  • 0 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 15 Dec 2022, 15:44.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

IMUN holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
500
Date
25 Jul 2022
Ownership
Direct
IMUN holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
15,607,998
Date
25 Jul 2022
Ownership
By Murphy Advisors, Inc.
IMUN holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
3,696,947
Date
25 Jul 2022
Ownership
By spouse
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

IMUN holding Derivative

Warrants (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
25 Jul 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,200
Exercise price
$50.00
IMUN holding Derivative

Warrants (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
25 Jul 2022
Ownership
By spouse
Underlying class
Common Stock
Underlying amount
500
Exercise price
$50.00
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Held by the spouse of the Reporting Person, the sole owner of Pixelheads, Inc.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .